These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11985390)

  • 41. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
    Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
    J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tongue force in patients with myasthenia gravis.
    Weijnen FG; Kuks JB; van der Bilt A; van der Glas HW; Wassenberg MW; Bosman F
    Acta Neurol Scand; 2000 Nov; 102(5):303-8. PubMed ID: 11083507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coats-like retinopathy in an infant with preclinical facioscapulohumeral dystrophy.
    Ganesh A; Kaliki S; Shields CL
    J AAPOS; 2012 Apr; 16(2):204-6. PubMed ID: 22525183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Facioscapulohumeral muscular dystrophy with severe mental retardation and epilepsy.
    Saito Y; Miyashita S; Yokoyama A; Komaki H; Seki A; Maegaki Y; Ohno K
    Brain Dev; 2007 May; 29(4):231-3. PubMed ID: 17010549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early-onset facioscapulohumeral muscular dystrophy type 1 with some atypical features.
    Dorobek M; van der Maarel SM; Lemmers RJ; Ryniewicz B; Kabzińska D; Frants RR; Gawel M; Walecki J; Hausmanowa-Petrusewicz I
    J Child Neurol; 2015 Apr; 30(5):580-7. PubMed ID: 24717985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acquired rippling muscle disease with myasthenia gravis.
    Greenberg SA
    Muscle Nerve; 2004 Jan; 29(1):143-6. PubMed ID: 14694511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Technical consideration for repetitive nerve stimulation].
    Sonoo M
    Rinsho Shinkeigaku; 2002 Jan; 42(1):54; author reply 55-6. PubMed ID: 12355856
    [No Abstract]   [Full Text] [Related]  

  • 48. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy.
    Goto K; Nishino I; Hayashi YK
    Neuromuscul Disord; 2006 Apr; 16(4):256-61. PubMed ID: 16545566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early-onset facioscapulohumeral muscular dystrophy - significance of pelvic extensors in sagittal spinal imbalance.
    Lee CS; Kang SJ; Hwang CJ; Lee SW; Ahn YJ; Kim YT; Lee DH; Lee MY
    J Pediatr Orthop B; 2009 Nov; 18(6):325-9. PubMed ID: 19620895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FSHD: a repeat contraction disease finally ready to expand (our understanding of its pathogenesis).
    Pearson CE
    PLoS Genet; 2010 Oct; 6(10):e1001180. PubMed ID: 21060814
    [No Abstract]   [Full Text] [Related]  

  • 51. Longstanding right-hand weakness in a patient with myasthenia gravis.
    de Carvalho M; Geraldes R
    Muscle Nerve; 2006 Nov; 34(5):670-1. PubMed ID: 16878322
    [No Abstract]   [Full Text] [Related]  

  • 52. [Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy].
    Su QX; Zhang C; Zeng Y; Lu XL; Liu XR; Wang ZH; Zhu YZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):581-4. PubMed ID: 14650163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rimmed vacuoles in facioscapulohumeral muscular dystrophy: a unique ultrastructural feature.
    Neudecker S; Krasnianski M; Bahn E; Zierz S
    Acta Neuropathol; 2004 Sep; 108(3):257-9. PubMed ID: 15221332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Very low penetrance in 85 Japanese families with facioscapulohumeral muscular dystrophy 1A.
    Goto K; Nishino I; Hayashi YK
    J Med Genet; 2004 Jan; 41(1):e12. PubMed ID: 14729852
    [No Abstract]   [Full Text] [Related]  

  • 55. Teaching Video NeuroImages: Inverted Beevor sign in facioscapulohumeral muscular dystrophy.
    Papadopoulos C; Xirou S; Kararizou E; Papadimas GK
    Neurology; 2020 Nov; 95(19):e2714. PubMed ID: 32817192
    [No Abstract]   [Full Text] [Related]  

  • 56. Cognitive impairment and cerebellar atrophy in typical onset 4Q35 fascioscapulohumeral dystrophy.
    Zouvelou V; Rentzos M; Zalonis I; Filippopolitis K; Manta P; Evdokimidis I
    Muscle Nerve; 2008 Nov; 38(5):1523-1524. PubMed ID: 18816620
    [No Abstract]   [Full Text] [Related]  

  • 57. Oculopharyngeal muscular dystrophy as a cause of progression of weakness in antibody positive myasthenia gravis.
    Oskarsson B; Ringel SP
    Neuromuscul Disord; 2013 Apr; 23(4):316-8. PubMed ID: 23453859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolated facial and bulbar paresis: a persistent manifestation of neonatal myasthenia gravis.
    Jeannet PY; Marcoz JP; Kuntzer T; Roulet-Perez E
    Neurology; 2008 Jan; 70(3):237-8. PubMed ID: 18195270
    [No Abstract]   [Full Text] [Related]  

  • 59. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy.
    van Overveld PG; Lemmers RJ; Sandkuijl LA; Enthoven L; Winokur ST; Bakels F; Padberg GW; van Ommen GJ; Frants RR; van der Maarel SM
    Nat Genet; 2003 Dec; 35(4):315-7. PubMed ID: 14634647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.
    Kalkman JS; Zwarts MJ; Schillings ML; van Engelen BG; Bleijenberg G
    Neurol Sci; 2008 Sep; 29 Suppl 2():S238-40. PubMed ID: 18690504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.